Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11959139 | 0.89 | PTGDR2 (0.54) | PTGDR2AKR1B1 | |
| SCHEMBL12205342 | 0.88 | PTGDR2 (0.37) | PTGDR2AKR1B1 | |
| SCHEMBL11959133 | 0.87 | PTGDR2 (0.48) | PTGDR2 | |
| SCHEMBL4394762 | 0.84 | PTGDR2 (0.67) | PTGDR2 | |
| SCHEMBL4958492 | 0.82 | PTGDR2 (0.46) | PTGDR2 | |
| SCHEMBL11959132 | 0.81 | PTGDR2 (0.44) | PTGDR2 | |
| SCHEMBL2483141 | 0.81 | PTGDR2 (0.75) | PTGDR2 | |
| SCHEMBL11959141 | 0.78 | PTGDR2 (0.46) | PTGDR2AKR1B1 | |
| SCHEMBL10058111 | 0.78 | PTGDR2 (0.47) | PTGDR2AKR1B1 | |
| SCHEMBL10974094 | 0.75 | PTGDR2 (0.61) | PTGDR2AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210000793-A1 | COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2021-01-07 | — | — | US | disclosed |
| US-8236963-B2 | Tricyclic spiro derivatives as CRTH2 modulators | MERCK SERONO SA (CH) | 2012-08-07 | — | — | US | disclosed |
| US-8236963-B2 | Tricyclic spiro derivatives as CRTH2 modulators | MERCK SERONO SA (CH) | 2012-08-07 | — | — | US | disclosed |
| US-8236963-B2 | Tricyclic spiro derivatives as CRTH2 modulators | MERCK SERONO SA (CH) | 2012-08-07 | — | — | US | disclosed |
| EP-1891075-B1 | TRICYCLIC SPIRO DERIVATIVES AS CRTH2 MODULATORS | MERCK SERONO SA (CH) | 2011-10-19 | — | — | EP | disclosed |
| US-20090318486-A1 | Tricyclic spiro derivatives as CRTH2 modulators | LABORATOIRES SERONO S.A. (CH) | 2009-12-24 | — | — | US | disclosed |
| US-20090318486-A1 | Tricyclic spiro derivatives as CRTH2 modulators | LABORATOIRES SERONO S.A. (CH) | 2009-12-24 | — | — | US | disclosed |
| US-20090318486-A1 | Tricyclic spiro derivatives as CRTH2 modulators | LABORATOIRES SERONO S.A. (CH) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210000793-A1 | COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS | TYR, NHERF1, FGF1 | PTGDR2 3856/4885AKR1B1 1155/4885 |
| US-20090318486-A1 | Tricyclic spiro derivatives as CRTH2 modulators | RORB, NR3C2, NR1H2 | PTGDR2 42/4885AKR1B1 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.